RFID In Pharmaceuticals Market (2026 - 2033)

RFID In Pharmaceuticals Market Summary

The global RFID in pharmaceuticals market size was valued at USD 6.0 billion in 2025 and is projected to grow from USD 6.4 billion in 2026 to USD 10.9 billion in 2033, at a CAGR of 7.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 48.0% in 2025. One of the key drivers is the growing implementation of regulatory guidelines aimed at ensuring a secure drug supply in response to the increasing prevalence of counterfeit drugs.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

In addition, there is a growing demand for efficient supply chain management in the pharmaceutical industry. The introduction of advanced Radio-frequency identification (RFID) technology and the increasing adoption of RFID tags for authentication, real-time tracking, and tracing of drugs are also expected to contribute to market growth. The growing incidences of counterfeit drugs is the primary driving factor behind the increased adoption of RFID technology in the pharmaceutical industry Pharmaceutical industries are incorporating radio frequency identification into their supply chain to make it more efficient and improve patient safety while saving time and reduce costs.Furthermore, the market growth of RFID technology is expected to be driven by significant product launches from key market players.

Analyst Perspective

The RFID in pharmaceuticals market is experiencing significant growth as companies increasingly focus on improving drug traceability, automation of inventory management, and supply chain transparency. The industry is moving away from traditional product identification to RFID enabled solutions that offer enhanced tracking capabilities of products, specifically valuable drugs such as biologics, vaccines, and injectable and helps in product authentication. RFID-powered medicine packaging and connected sensors for tracking are some of recent advancements in this sector that are driving the pharma industry to deal with the threats of counterfeiting and enhance operational efficiency while maintaining compliance with strict regulatory policies. With a rising focus on drug traceability and authenticity to ensure safer, compliant and resilient distribution, The RFID in pharmaceutical market is expected to grow steadily with the growing adoption across sectors such as manufacturing, distribution, and hospital pharmacy operations.

Component Insights

The RFID tags segment held the largest market share of over 40.0% in 2025, owing to rising awareness about the benefits of these tags, which is expected to drive the growth of this segment. Tags can be utilized at various locations to track and trace different types of drugs, vaccines, and other medical products. These factors contribute to the dominance of this segment during the forecast period.

Furthermore, it enables easy access to inventory management, faster workflow processing, and real-time drug monitoring, drug usage, and reduce the drug counterfeiting, these factors are also expected to contribute to the segment growth.

RFID Readers accounted a significant revenue share in 2025. These readers are used to collect information from tags, aiding in object tracking. Data is transmitted from the tag to the reader using radio waves. Additionally, these readers can be combined with technologies like GPS and sensors, making them valuable in logistics, transportation, and supply chain management. Furthermore, with the advancements in data analytics and cloud computing, readers can offer real-time insights and analytics, which help optimize processes and enhance decision-making.

Type Insights

In 2025, the chipped RFID segment had the largest market share, accounting for over 60.0%. This technology involves in implementing RFID chips into pharmaceutical products, creating a unique identifier for each product. This enables real-time authentication throughout the supply chain. With chipped radio frequency identification, manufacturers can verify the authenticity of drugs at every stage, from production to distribution. This helps to mitigate the risks associated with counterfeit drugs, ensuring that patients receive correct and safe medications.

Chip less RFID segment is expected to gain popularity in the pharmaceutical industry over the forecast period, due to this technology overcomes the hardware limitations encountered by chipped technology. As chip less technology continues to advance, pharmaceutical companies can benefit from streamlined operations, cost reduction, improved counterfeit drug detection, and enhanced patient safety.

Application Insights

The drug tracking and tracing held the largest market share of over 50.0% in 2025. This segment's growth is driven by increasing incidences of counterfeit drugs and the widespread adoption of advanced RFID technology in pharmaceutical industry.

The drug quality and management segment are anticipated to witness the fastest growth over the forecast period. Drug quality management practices can help pharmaceutical manufacturers and healthcare providers to ensure the integrity and safety of their products. By implementing effective quality management system, manufacturers can maintain high standards and safety of the patient health.

End user Insights

The drug manufacturers segment held the largest market share of over 40.0% in 2025. This growth can be attributed to several factors, including rising adoption of advanced RFID technology to identify counterfeit drugs and the benefits of drug tracking systems in streamlining efficient workflows between pharmaceutical organization, wholesaler, distributors and healthcare organization.

There has been a rise in the proliferation and distribution of counterfeit drugs, which affect significant health risks. Radio frequency identification technology assist in detecting such counterfeit drugs and helps manufacturers refrain from distributing them in the market. Additionally, this technology helps in inventory management and reduces labelling errors, further driving the growth of this segment.

Furthermore, the hospitals and clinics is expected to experience significant growth during the forecast period. This can be attributed to various factors, such as the adoption of RFID technology to avoid counterfeit drugs, ensuring patient safety, and the cost reduction associated with supply chain management are the key factors driving the growth of the segment.

Regional Insights

In 2025, North America held the largest market share of over 48.0% in the market. This can be attributed to the increasing risks associated with substandard and falsified drugs and the presence of stringent regulatory frameworks in the region.

To learn more about this report, Download Free Sample Report

Moreover, significant advancement in RFID technologies and of presence of key market players in the region is also contributing to the market growth. For instance, in November 2025, Impinj, Inc upgraded its RAIN RFID platform by introducing Gen2X innovations, that delivers new functionalities for its M770 and M780 endpoint ICs. The upgrade delivers better tag reading and identification with enhanced authentication and identification in logistics and healthcare use cases.

Asia Pacific RFID In Pharmaceuticals Market Trends

Asia Pacific is projected to witness the fastest growth during the forecast period. This growth can be attributed to the increasing number of pharmaceutical companies in the region and their growing demand for efficient supply chain management. In addition, the presence of a large pharmaceutical industry and improving healthcare infrastructure are key factors contributing to the regional growth.

Key RFID In Pharmaceuticals Market Companies Insights

The RFID in pharmaceuticals industry features a range of global, regional, and local players, making it a competitive market. The key companies are using partnerships, collaborations, acquisitions, mergers, and agreements as strategies to withstand the intense competition and increase their market share. For instance, in October 2025, Schreiner MediPharm (Schreiner Group) introduced a syringe application label with integrated RFID capabilities. It offers product security, authentication and digital identification of medication packaging.

Key RFID In Pharmaceuticals Companies

The following key companies have been profiled for this study on the RFID in pharmaceuticals market:

• Zebra Technologies Corp.

• CCL Industries Inc.

• Fresenius Kabi AG

• Avery Dennison Corporation.

• Impinj, Inc.

• Bluesight.

• Terso Solutions Inc.

• GAO Group

• Tageos

• Alien Technology, LLC.

Recent Developments

• In January 2026, SAG RFID Securitag Assembly Group Co., LTD, announced the launch of LiquidMate O, a UHF RFID label, built for directly on-vial RFID tagging of liquid filled injectable drugs. The solution provides additional value to help pharmaceutical producers track inventory, adhere to regulation and increase supply chain transparency.

• In September 2024, Becton, Dickinson and Company (BD) and AVERY DENNISON CORPORATION, introduced RFID based digital identification solutions for prefilled syringes to present it in January at Pharmapack Europe 2025. The RFID identification solution embeds RFID tags into the parts of the syringe in order to ensure unique device identification, thus facilitating tracing, verification, as well as lifecycle visibility of the drug products.

Global RFID In Pharmaceuticals Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global RFID in pharmaceuticals market report based on component, type, application, end user, region:

• Component Outlook (Revenue, USD Billion, 2021 - 2033)

  • RFID Tags

  • RFID Readers

  • RFID Middleware

• Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Chipped RFID

  • Chipless RFID

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Drug Track & Tracing Systems

  • Drug Quality Management

  • Others

• End user Outlook (Revenue, USD Billion, 2021 - 2033)

  • Drug Manufacturers

  • Hospitals & Clinics

  • Others (Distributors, Retailers)

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait